HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
FRA10AC1
FRA10A associated CGG repeat 1
Chromosome 10 Β· 10q23.33
NCBI Gene: 118924Ensembl: ENSG00000148690.13HGNC: HGNC:1162UniProt: Q70Z53
29PubMed Papers
21Diseases
0Drugs
12Pathogenic Variants
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein bindingmRNA splicing, via spliceosomenucleusneurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalitiesNeurodevelopmental disorderDNA methylationgenetic disorder
✦AI Summary

FRA10AC1 is a nuclear protein functioning as a peripheral component of the spliceosomal C complex involved in pre-mRNA splicing 1. The gene contains a polymorphic CGG trinucleotide repeat in its 5'UTR that can expand beyond 200 repeats, leading to DNA hypermethylation and gene silencingβ€”a mechanism implicated in neurodevelopmental disorders 23. FRA10AC1 interacts with other spliceosomal proteins including ESS2 and DGCR14, forming a dense protein interaction network with disease-associated splicing factors 4. Biallelic pathogenic variants in FRA10AC1 cause a neurodevelopmental disorder characterized by developmental delay, intellectual disability, microcephaly, corpus callosum hypoplasia or agenesis, growth retardation, and craniofacial dysmorphism 15. Additional features may include skeletal defects, congenital heart disease, renal anomalies, and ocular abnormalities 5. Loss-of-function variants result in drastically reduced or absent FRA10AC1 expression, while missense variants can impair protein stability 1. The disorder represents a spliceosomopathy where disrupted pre-mRNA processing likely contributes to neurodevelopmental pathology, though FRA10AC1 may possess additional cellular functions coupling transcription and splicing 1.

Sources cited
1
FRA10AC1 is a peripheral spliceosomal C complex protein; biallelic variants cause neurodevelopmental disorder with developmental delay, intellectual disability, microcephaly, corpus callosum abnormalities, growth retardation, and craniofacial dysmorphism
PMID: 34694367
2
FRA10AC1 contains a polymorphic CGG repeat in its 5'UTR that expands beyond 200 repeats and undergoes methylation; encodes a nuclear protein with unknown function
PMID: 15203205
3
CGG repeat expansions in FRA10AC1 are implicated in neurodevelopmental disorders through repeat expansion-mediated epigenetic silencing and gene expression perturbation
PMID: 37768318
4
FRA10AC1 is a non-core spliceosomal component interacting with spliceosomal proteins ESS2 and SF3B2; extensive interconnectivity with disease-associated spliceosomal components in its protein interaction network
PMID: 36980839
5
FRA10AC1-related disorder includes developmental delay, intellectual disability, dysmorphic facies, growth retardation, corpus callosum abnormalities, skeletal/cardiac defects, renal anomalies, and ocular abnormalities
PMID: 41571908
Disease Associationsβ“˜21
neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalitiesOpen Targets
0.76Strong
Neurodevelopmental disorderOpen Targets
0.37Weak
DNA methylationOpen Targets
0.29Weak
genetic disorderOpen Targets
0.19Weak
diabetic ketoacidosisOpen Targets
0.02Suggestive
myelodysplastic syndromeOpen Targets
0.00Suggestive
type 1 diabetes mellitusOpen Targets
0.00Suggestive
adrenocortical carcinoma, hereditaryOpen Targets
0.00Suggestive
cervical cancerOpen Targets
0.00Suggestive
clear cell renal carcinomaOpen Targets
0.00Suggestive
colorectal adenocarcinomaOpen Targets
0.00Suggestive
gastric cancerOpen Targets
0.00Suggestive
glioma susceptibility 1Open Targets
0.00Suggestive
hepatocellular carcinomaOpen Targets
0.00Suggestive
lung cancerOpen Targets
0.00Suggestive
ThymomaOpen Targets
0.00Suggestive
thyroid cancer, nonmedullary, 1Open Targets
0.00Suggestive
urinary bladder cancerOpen Targets
0.00Suggestive
Uterine CarcinosarcomaOpen Targets
0.00Suggestive
Uveal MelanomaOpen Targets
0.00Suggestive
Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalitiesUniProt
Pathogenic Variants12
NM_145246.5(FRA10AC1):c.491AAG[1] (p.Glu165del)Pathogenic
not provided|Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities
β˜…β˜…β˜†β˜†2025β†’ Residue 165
NM_145246.5(FRA10AC1):c.481C>T (p.Arg161Ter)Pathogenic
Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities|See cases|Acute myeloid leukemia|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 161
NM_145246.5(FRA10AC1):c.328C>T (p.Arg110Ter)Pathogenic
Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities
β˜…β˜…β˜†β˜†2025β†’ Residue 110
NM_145246.5(FRA10AC1):c.380+1G>APathogenic
Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities
β˜…β˜…β˜†β˜†2025
NM_145246.5(FRA10AC1):c.51_52del (p.Cys17fs)Pathogenic
Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities
β˜…β˜…β˜†β˜†2024β†’ Residue 17
NM_145246.5(FRA10AC1):c.103C>T (p.Gln35Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 35
NM_145246.5(FRA10AC1):c.453T>G (p.Tyr151Ter)Likely pathogenic
Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities
β˜…β˜†β˜†β˜†2025β†’ Residue 151
NM_145246.5(FRA10AC1):c.626-1G>CLikely pathogenic
Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities
β˜…β˜†β˜†β˜†2025
NM_145246.5(FRA10AC1):c.76del (p.Arg26fs)Likely pathogenic
Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities
β˜…β˜†β˜†β˜†2024β†’ Residue 26
NC_000010.11:g.93695674_93708392delinsTTAGTACACPathogenic
Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities
β˜†β˜†β˜†β˜†2022
NM_001347714.2(FRA10AC1):c.-269_77+32delPathogenic
Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities
β˜†β˜†β˜†β˜†2022
NM_145246.5(FRA10AC1):c.561_562insTTTA (p.Ser188fs)Pathogenic
Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities
β˜†β˜†β˜†β˜†2022β†’ Residue 188
View on ClinVar β†—
Related Genes
HNRNPA1L3Shared pathway100%RBMXL1Shared pathway100%RBMY1EShared pathway100%RBMY1DShared pathway100%RBM44Shared pathway100%HNRNPA3Shared pathway100%
Tissue Expression6 tissues
Ovary
100%
Brain
84%
Heart
83%
Liver
61%
Bone Marrow
56%
Lung
46%
Gene Interaction Network
Click a node to explore
FRA10AC1HNRNPA1L3RBMXL1RBMY1ERBMY1DRBM44HNRNPA3
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q70Z53
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
1.81LoF Tolerant
pLIβ“˜
0.05Tolerant
Observed/Expected LoF0.88 [0.39–1.81]
RankingsWhere FRA10AC1 stands among ~20K protein-coding genes
  • #12,149of 20,598
    Most Researched29
  • #2,710of 5,498
    Most Pathogenic Variants12
  • #16,605of 17,882
    Most Constrained (LOEUF)1.81
Genes detectedFRA10AC1
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Unravelling the link between neurodevelopmental disorders and short tandem CGG-repeat expansions.
PMID: 37768318
Emerg Top Life Sci Β· 2023
1.00
2
Reconstruction of a Comprehensive Interactome and Experimental Data Analysis of FRA10AC1 May Provide Insights into Its Biological Role in Health and Disease.
PMID: 36980839
Genes (Basel) Β· 2023
0.90
3
Biallelic FRA10AC1 variants cause a neurodevelopmental disorder with growth retardation.
PMID: 34694367
Brain Β· 2022
0.80
4
[Clinical phenotype and genetic analysis of a child with partial duplication of 10q and a literature review].
PMID: 39528289
Zhonghua Yi Xue Yi Chuan Xue Za Zhi Β· 2024
0.70
5
Folate-sensitive fragile site FRA10A is due to an expansion of a CGG repeat in a novel gene, FRA10AC1, encoding a nuclear protein.
PMID: 15203205
Genomics Β· 2004
0.60